Biodesix, Inc. (BDSX)
6.80
+0.08
(+1.19%)
USD |
NASDAQ |
Dec 31, 16:00
Biodesix Cash from Investing (Quarterly): -0.067M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | -4.123B |
| FONAR Corp. | -2.367M |
| XWELL, Inc. | 1.715M |
| ProPhase Labs, Inc. | 0.00 |
| Veracyte, Inc. | 48.26M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.879M |
| Cash from Financing (Quarterly) | 4.822M |
| Free Cash Flow | -29.33M |
| Free Cash Flow Per Share (Quarterly) | -1.193 |
| Free Cash Flow to Equity (Quarterly) | -9.733M |
| Free Cash Flow to Firm (Quarterly) | -6.872M |
| Free Cash Flow Yield | -5.60% |